DXYN Financial Statements & Analysis
Complete financial statements for DXYN including income statement, balance sheet, and cash flow statement. Analyze DXYN's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
Income Statement
Revenue
-2.9% ↓
Net Income
41.4% ↑
Gross Margin
9.3% ↑
Operating Margin
132.1% ↑
Balance Sheet
Current Ratio
-10.3% ↓
Debt to Equity
81.0% ↓
Asset Turnover
-2.5% ↓
Cash Flow
Operating Cash Flow
182.8% ↑
Net Cash Flow
5408.3% ↑
Free Cash Flow
650.7% ↑
Cash Flow to Debt
188.0% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2024 | 2025 | Change | Impact |
|---|---|---|---|---|
| Revenue | 265.03M | 257.43M | 2.9% | |
| Gross Profit | 65.51M | 69.55M | 6.2% | |
| Operating Income | -5.87M | 1.83M | 131.2% | |
| Net Income | -13.00M | -7.62M | 41.4% | |
| EPS | -0.90 | -0.53 | 41.1% | |
| EBITDA | 507.00K | 6.99M | 1278.9% | |
| Gross Margin | 24.72% | 27.02% | 9.3% | |
| Operating Margin | -2.21% | 0.71% | 132.1% | |
| Net Income Margin | -4.91% | -2.96% | 39.7% | |
| R&D Expenses | 0 | 0 | 0.0% |
Income Statement Full Table
Free users can view the last 3 periods. Upgrade to see the full history.
Upgrade| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 257.43M | 265.03M | 276.34M | — | — |
| Gross Profit | 69.55M | 65.51M | 73.88M | — | — |
| Operating Income | 1.83M | -5.87M | 5.05M | — | — |
| Net Income | -7.62M | -13.00M | -2.72M | — | — |
| EPS | -0.53 | -0.90 | -0.18 | — | — |
| EBITDA | 6.99M | 507.00K | 12.81M | — | — |
| Gross Margin | 27.02% | 24.72% | 26.73% | — | — |
| Operating Margin | 0.71% | -2.21% | 1.83% | — | — |
| Net Income Margin | -2.96% | -4.91% | -0.98% | — | — |
| R&D Expenses | 0 | 0 | 0 | — | — |
Financial Metrics
Want to dive deeper into DXYN's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.
View Financial Metrics